Accelerate Your AmbitionTM
At Integrium, we understand the need for speed.
We know that you need answers. Quickly.
We can help you obtain the reliable, accurate data you need to make informed decisions, reach inflection points and make go or no-go decisions.
IntegriumQT is dedicated to delivering early phase results fast.
But we’re also proud of our proven track record of delivering results that are consistently accurate, reliable and communicated with clarity and precision.
Generally, in as few as 90 days, we can help you complete:
- IND Creation
- Protocol Development
- Study Conduct
- IRB Submission
- Topline Results
IntegriumQT conducts Phase I/PK studies:
- First-in-Human Studies
- Pharmacokinetics / Pharmacodynamics
- Proof of Concept
- Single / Multiple Ascending Dose
- Special Populations
- Dose Ranging
- Thorough QT/QTc
- Maximum Tolerated Dose
- Food Effect
- Bioavailability / Bioequivalence
- Drug-Drug Interaction
IntegriumQT accelerated Phase I studies feature:
- Expert Study Design and Protocol Writing
- Rapid Enrollment
- Fully-Equipped 50-Bed Clinical Research Unit with:
- Extensive Subject Database
- ECG, ABPM, Holter Monitoring
- Thorough QT/QTc, Telemetry
- Medical Monitoring
- Data Management and Biostatistics
- Clinical Study Reports